Comparative analysis between cardiovascular disease prevention guidelines in clinical, European, American and Costa Rican practice between 2016 and 2019
PDF (Español (España))
XPS (Español (España))
JPG (Español (España))
صندلی اداری سرور مجازی ایران Decentralized Exchange

How to Cite

1.
Benítez Arrieta MM, Sandoval Espinoza VI, Mendoza Rodríguez FF. Comparative analysis between cardiovascular disease prevention guidelines in clinical, European, American and Costa Rican practice between 2016 and 2019. Rev.méd.sinerg. [Internet]. 2022Jul.1 [cited 2024May17];7(7):e868. Available from: https://www.revistamedicasinergia.com/index.php/rms/article/view/868

Abstract

Introduction: Cardiovascular diseases have been increasing in recent years, becoming the main causes of death worldwide, this due to the impoverishment of current lifestyles that have forced them to have an accelerated rate with slight awareness of health. Among the main diseases are high blood pressure, type II diabetes, coronary heart disease and strokes. Methodology: A comparison was made between the three cardiovascular prevention guides, taking structure, content and quality as variables, for the structure and content variable, information was collected from the guides that were subsequently tabulated to observe the differences between them, for the quality variable the AGREE II instrument was used, consisting of six domains divided into 23 items, which evaluate different aspects of the guidelines, the use of the instrument required the help of four evaluators, a cardiology specialist, a general practitioner, a university intern and a medical student . Results: The Costa Rican guide in the evaluation of structure and content stood out above the other guides, by meeting the highest number of indicators, while in the quality evaluation the American guide obtained first place with 78%, followed by the guide Costa Rican with 77% and with a lower level of quality the European guide with 70%. Conclusion: The American guide stood out in the evaluation given by AGREE II in terms of quality, followed by the Costa Rican guide and finally the one with the lowest score was the European guide with significant deficiencies in content and compliance with the evaluation instrument criteria. Although the American guide obtained the best quality rating, it was not the guide with a remarkable content since the Costa Rican guide has been adapted to the current population and its diversity.

https://doi.org/10.31434/rms.v7i7.868

Keywords

heart. cardiovascular diseases. american heart association. guideline. epidemiology. Costa Rica.
PDF (Español (España))
XPS (Español (España))
JPG (Español (España))

References

Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. [Internet]. 2018. Disponible en: https://www.framinghamheartstudy.org/fhs-about/about-fhs-en-espanol/

O"Donnel CJ, Elosua R. Factores de riesgo cardiovascular. Perspectivas derivadas del Framingham Heart Study. Rev Esp Cardiol. 2009;61(03):299–310. Disponible en: DOI: 10.1157/13116658

Grundy SM, Bailey AL, Stone NJ. Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 25 de junio de 2019;73(24):e285–350. Disponible en: DOI: 10.1016/j.jacc.2018.11.002

Wood D, De Backer G, Faergeman O, Graham I, Mancia G, Pyörälä K. Prevention of coronary heart disease in clinical practice. Eur Heart J. octubre de 1998;19:1434–503. Disponible en: DOI: 10.1053/euhj.1998.1243

Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 1 de agosto de 2016;37(29):2315–81. DOI: 10.1093/eurheartj/ehw106

Hernando S, J F, Martín Conejero A. Enfermedad arterial periférica: aspectos fisiopatológicos, clínicos y terapéuticos. Rev Esp Cardiol. 2008;60(9):969–82. DOI: 10.1157/13109651

Jiménez MF, Castro A, Bretón I, Gomez F. Comentarios a la guía ESC 2019 sobre diabetes, prediabetes y enfermedad cardiovascular. Rev Esp Cardiol [Internet]. 2020 [citado 3 de mayo de 2020]; Disponible en: http://www.revespcardiol.org/es-comentarios-guia-esc-2019-sobre-avance-S0300893219305500?referer=buscador

Sánchez JC, Duarte M, Sánchez R, Peña N. Plan de Atención a la Salud de las Personas 2001- 2006: Caja Costarricense de Seguro Social. [Internet]. 2001. Disponible en: https://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S1409-14292006000100003#35

.Sáenz MR, López E, Villalobos D, Gamboa C. Políticas Nacionales de Salud 2002-2006: Ministerio de Salud, Caja Costarricense de Seguro Social 2002. Disponible en: https://www.healthresearchweb.org/files/POLITICA_NACIONAL_SALUD_2002-2006.pdf

Angulo JM, Arias M, Duarte P, Monge C. Guía para la Prevención de las Enfermedades Cardiovasculares [Internet]. 2016 [citado 6 de enero de 2022]. Disponible en: https://repositorio.binasss.sa.cr/repositorio/bitstream/handle/20.500.11764/409/2015enfermedadescardiovasculares.pdf?sequence=1&isAllowed=y

Brouwers M, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna S, Littlejohns P, Makarski J, Zitzelsberger L. AGREE Next Steps Consortium. AGREE II: Advancing guideline development, reporting and evaluation in healthcare. [Internet]. Can Med Assoc J.; 2010. Disponible en: doi:10.1503/cmaj.090449

Organización Panamericana de la Salud. Las ENT de un vistazo: Mortalidad de las enfermedades no transmisibles y prevalencia de sus factores de riesgo en la Región de las Américas. Washington, D.C.: OPS; 2019. Disponible en: https://iris.paho.org/handle/10665.2/51752

Organizacion Mundial de la Salud. Enfermedades cardiovasculares [Internet]. Ginebra, Suiza:WHO. 2018 [citado 14 de enero 2022]. Disponible en: http://www.who.int/topics/cardiovascular_diseases/es/

Marín R, Angulo JM, Duarte P. Situación Salud 2018: Ministerio de Salud. 2019. Disponible en: https://www.binasss.sa.cr/opacms/media/digitales/An%C3%A1lisis%20Integral%20de%20Situaci%C3%B3n%20de%20Salud.%20Costa%20Rica%202019.pdf

José M. Romero. Enfermedad Arterial Periférica [Internet]. Medical DOSPLUS; 2010. Disponible en: http://www.podologiaeuskadi.com/Enfermedad_arterial_periferica.pdf

Gonzalez Rodríguez R, Martínez Cruz M. Caracterización clínico-epidemiológica de la hipertensión arterial en adultos mayores [Internet]. Policlínico Universitario Pedro Borrás Astorga; 2017. Disponible en: http://www.revfinlay.sld.cu/index.php/finlay/article/view/520

Antonio Arauz AR. Enfermedad vascular cerebral. Revista de la Facultad de Medicina de la UNAM. 2012;55:11–21. Disponible en: http://www.scielo.org.mx/scielo.php?pid=S0026-17422012000300003&script=sci_abstract

Bejarano L, María J, Brotons Cuixart C. Factores de riesgo cardiovascular y atención primaria: evaluación e intervención. Aten Primaria. 2010;668–77. Disponible en: doi: 10.1016/j.aprim.2011.10.002

Humphreys J. SIAC | Nueva Guía de Hipertensión 2017 | SIAC [Internet]. [citado 3 de mayo de 2020]. Disponible en: http://www.siacardio.com/educacion/guias/nueva-guia-de-hipertension-2017/

Alvarado MA, Angulo JM, Duarte P, Monge C. Guias para la Detección, Diagnóstico y Tratamiento de la Hipertensión Arterial: Caja Costarricense de Seguro Social; 2009. [Internet].Disponible en: https://www.binasss.sa.cr/protocolos/hipertension.pdf

Burguez S. Insuficiencia cardíaca aguda. Revista Uruguaya Cardiologia. 2017;32:372–92. Disponible en: http://www.scielo.edu.uy/pdf/ruc/v32n3/1688-0420-ruc-32-03-370.pdf

Lavalle Cobo A, Sanabria H. Guías sobre diabetes, prediabetes y desarrollo de enfermedad cardiovascular de la Sociedad Europea de Cardiología (ESC) en colaboración con la Asociación Europea para el Estudio Diabetes (EASD) 2019 [Internet]. Sociedad Argentina de Cardiología; 2019. Disponible en: https://www.sac.org.ar/novedades-bibliograficas/guias-diabetes-esc-2019/

Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASDThe Task Force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Eur Heart J [Internet]. 2019 [citado 6 de enero de 2022]; Disponible en: https://academic.oup.com/eurheartj/advance-article/doi/10.1093/eurheartj/ehz486/5556890

Gonzalez RD. Tabaquismo o fumar tabaco es un riesgo cardiovascular: Fundacion Española del Corazon 2016 [Internet]. [citado 21 febrero del 2022]. Disponible en: http://www.fundaciondelcorazon.com/prevencion/riesgo-cardiovascular/fumar-tabaco-tabaquismo.html

Liras A, Martín S. Tabaquismo: Fisiopatología y prevención. Revista de Investigacion Clínica. 2008;59:278–89. Disponible en: https://www.medigraphic.com/pdfs/revinvcli/nn-2007/nn074f.pdf

Brouwers M, Kho ME, Browman GP, Burgers JS, Cluzeau F, Feder G, Fervers B, Graham ID, Grimshaw J, Hanna S, Littlejohns P, Makarski J, Zitzelsberger L. INSTRUMENTO AGREE II PARA LA EVALUACIÓN DE GUÍAS DE PRÁCTICA CLÍNICA [Internet]. Consorcio AGREE; 2010. Disponible en: https://www.agreetrust.org/wp-content/uploads/2013/06/AGREE_II_Spanish.pdf

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Copyright (c) 2022 Array

Downloads

Download data is not yet available.
فروشگاه اینترنتی صندلی اداری جوراب افزایش قد ژل افزایش قد صندلی اداری